Review




Structured Review

Jackson Laboratory cd8 knockout ko mice
Immunogenicity increases upon GFER depletion in PDAC cells. A–E, Gene set enrichment analysis of RNA-seq data reveals the upregulation of the IFNα response ( A ), IFNγ response ( B ), TNFα signaling via NFκB ( C ), inflammatory response ( D ), and IL2–STAT5 signaling ( E ) pathways in GFER-depleted PATC 124 cells infected with sgGFER. A total of 100,000 PATC cells were cultured in six-well plates for 7 days and then measured. F, RNA-seq analysis demonstrates significant changes in gene expression in orthotopic tumor samples derived from 10,000 KPC (p53 mut) cells infected with nontargeting shRNA ( n = 2) as well as shGFER (shGFER#4, n = 2; shGFER#5, n = 3). Tumors were harvested when all tumors were of comparable size. Immune system–related genes are highlighted in red boxes. G, Protein levels of chemokines ( CXCL9, CXCL10 , and CXCL11 ) related to <t>CD8</t> + T-cell infiltration in orthotopic shCTRL and shGFER KPC (p53 mut) tumors. Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 4 mice. H and I, Immunophenotyping of orthotopic shCTRL and shGFER KPC tumors. A total of 10,000 KPC cells were injected into the pancreas, and tumors were harvested for multicolor flow cytometry analysis. The percentage of CD8 + T cells, CD4 + T cells, NK cells (NK1.1+ cells), B cells (B220+ cells), macrophages (F4/80+ cells), and dendritic cells (DC; CD11c + cells) were identified in CD45 + cells ( H ). The percentage of PD-1–positive and granzyme B–positive cells were identified in CD8 + and CD8 + PD-1 + cells, respectively ( I ). Fibroblasts were identified as CD45 − EpCAM − αSMA + cells ( J ). Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 5 mice. K, Kaplan–Meier survival analysis of C57BL/6 mice orthotopically implanted with 10,000 KPC (p53 mut) cells infected with shCTRL or shGFER. Mice received either anti-CD8 antibody (10 mg/kg) or rat IgG2a starting 1 day prior to surgery and then intraperitoneally every 7 days for four cycles. Animals were euthanized when tumor volume reached ∼2000 mm 3 . Survival curves were analyzed by one-way ANOVA ( n = 10 per group). L, Growth curves of 10,000 KPC (p53 mut) cells subcutaneously implanted into C57BL/6 mice. Prior to implantation, KPC cells were infected with shCTRL or shGFER. Tumor-bearing mice were treated with IgG control or anti–PD-1 antibodies. Tumor volume was measured every 4 days for 36 days. Statistical analysis was performed using one-way ANOVA. Data represent the mean ± SD; n = 4–7 per group. M, Pancreatic cancer patient with anti–PD-1/anti-CD40 treatment prior to chemotherapy were selected from the PRINCE trial and divided in to GFER-high and -low groups. The overall survival analysis was done with log-rank test ( N = 17).
Cd8 Knockout Ko Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pmc13055638-134-23-29?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
cd8 knockout ko mice - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma"

Article Title: GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma

Journal: Cancer Research

doi: 10.1158/0008-5472.CAN-24-4211

Immunogenicity increases upon GFER depletion in PDAC cells. A–E, Gene set enrichment analysis of RNA-seq data reveals the upregulation of the IFNα response ( A ), IFNγ response ( B ), TNFα signaling via NFκB ( C ), inflammatory response ( D ), and IL2–STAT5 signaling ( E ) pathways in GFER-depleted PATC 124 cells infected with sgGFER. A total of 100,000 PATC cells were cultured in six-well plates for 7 days and then measured. F, RNA-seq analysis demonstrates significant changes in gene expression in orthotopic tumor samples derived from 10,000 KPC (p53 mut) cells infected with nontargeting shRNA ( n = 2) as well as shGFER (shGFER#4, n = 2; shGFER#5, n = 3). Tumors were harvested when all tumors were of comparable size. Immune system–related genes are highlighted in red boxes. G, Protein levels of chemokines ( CXCL9, CXCL10 , and CXCL11 ) related to CD8 + T-cell infiltration in orthotopic shCTRL and shGFER KPC (p53 mut) tumors. Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 4 mice. H and I, Immunophenotyping of orthotopic shCTRL and shGFER KPC tumors. A total of 10,000 KPC cells were injected into the pancreas, and tumors were harvested for multicolor flow cytometry analysis. The percentage of CD8 + T cells, CD4 + T cells, NK cells (NK1.1+ cells), B cells (B220+ cells), macrophages (F4/80+ cells), and dendritic cells (DC; CD11c + cells) were identified in CD45 + cells ( H ). The percentage of PD-1–positive and granzyme B–positive cells were identified in CD8 + and CD8 + PD-1 + cells, respectively ( I ). Fibroblasts were identified as CD45 − EpCAM − αSMA + cells ( J ). Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 5 mice. K, Kaplan–Meier survival analysis of C57BL/6 mice orthotopically implanted with 10,000 KPC (p53 mut) cells infected with shCTRL or shGFER. Mice received either anti-CD8 antibody (10 mg/kg) or rat IgG2a starting 1 day prior to surgery and then intraperitoneally every 7 days for four cycles. Animals were euthanized when tumor volume reached ∼2000 mm 3 . Survival curves were analyzed by one-way ANOVA ( n = 10 per group). L, Growth curves of 10,000 KPC (p53 mut) cells subcutaneously implanted into C57BL/6 mice. Prior to implantation, KPC cells were infected with shCTRL or shGFER. Tumor-bearing mice were treated with IgG control or anti–PD-1 antibodies. Tumor volume was measured every 4 days for 36 days. Statistical analysis was performed using one-way ANOVA. Data represent the mean ± SD; n = 4–7 per group. M, Pancreatic cancer patient with anti–PD-1/anti-CD40 treatment prior to chemotherapy were selected from the PRINCE trial and divided in to GFER-high and -low groups. The overall survival analysis was done with log-rank test ( N = 17).
Figure Legend Snippet: Immunogenicity increases upon GFER depletion in PDAC cells. A–E, Gene set enrichment analysis of RNA-seq data reveals the upregulation of the IFNα response ( A ), IFNγ response ( B ), TNFα signaling via NFκB ( C ), inflammatory response ( D ), and IL2–STAT5 signaling ( E ) pathways in GFER-depleted PATC 124 cells infected with sgGFER. A total of 100,000 PATC cells were cultured in six-well plates for 7 days and then measured. F, RNA-seq analysis demonstrates significant changes in gene expression in orthotopic tumor samples derived from 10,000 KPC (p53 mut) cells infected with nontargeting shRNA ( n = 2) as well as shGFER (shGFER#4, n = 2; shGFER#5, n = 3). Tumors were harvested when all tumors were of comparable size. Immune system–related genes are highlighted in red boxes. G, Protein levels of chemokines ( CXCL9, CXCL10 , and CXCL11 ) related to CD8 + T-cell infiltration in orthotopic shCTRL and shGFER KPC (p53 mut) tumors. Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 4 mice. H and I, Immunophenotyping of orthotopic shCTRL and shGFER KPC tumors. A total of 10,000 KPC cells were injected into the pancreas, and tumors were harvested for multicolor flow cytometry analysis. The percentage of CD8 + T cells, CD4 + T cells, NK cells (NK1.1+ cells), B cells (B220+ cells), macrophages (F4/80+ cells), and dendritic cells (DC; CD11c + cells) were identified in CD45 + cells ( H ). The percentage of PD-1–positive and granzyme B–positive cells were identified in CD8 + and CD8 + PD-1 + cells, respectively ( I ). Fibroblasts were identified as CD45 − EpCAM − αSMA + cells ( J ). Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 5 mice. K, Kaplan–Meier survival analysis of C57BL/6 mice orthotopically implanted with 10,000 KPC (p53 mut) cells infected with shCTRL or shGFER. Mice received either anti-CD8 antibody (10 mg/kg) or rat IgG2a starting 1 day prior to surgery and then intraperitoneally every 7 days for four cycles. Animals were euthanized when tumor volume reached ∼2000 mm 3 . Survival curves were analyzed by one-way ANOVA ( n = 10 per group). L, Growth curves of 10,000 KPC (p53 mut) cells subcutaneously implanted into C57BL/6 mice. Prior to implantation, KPC cells were infected with shCTRL or shGFER. Tumor-bearing mice were treated with IgG control or anti–PD-1 antibodies. Tumor volume was measured every 4 days for 36 days. Statistical analysis was performed using one-way ANOVA. Data represent the mean ± SD; n = 4–7 per group. M, Pancreatic cancer patient with anti–PD-1/anti-CD40 treatment prior to chemotherapy were selected from the PRINCE trial and divided in to GFER-high and -low groups. The overall survival analysis was done with log-rank test ( N = 17).

Techniques Used: Immunopeptidomics, RNA Sequencing, Infection, Cell Culture, Gene Expression, Derivative Assay, shRNA, Two Tailed Test, Injection, Flow Cytometry, Control



Similar Products

86
Jackson Laboratory cd8 knockout ko mice
Immunogenicity increases upon GFER depletion in PDAC cells. A–E, Gene set enrichment analysis of RNA-seq data reveals the upregulation of the IFNα response ( A ), IFNγ response ( B ), TNFα signaling via NFκB ( C ), inflammatory response ( D ), and IL2–STAT5 signaling ( E ) pathways in GFER-depleted PATC 124 cells infected with sgGFER. A total of 100,000 PATC cells were cultured in six-well plates for 7 days and then measured. F, RNA-seq analysis demonstrates significant changes in gene expression in orthotopic tumor samples derived from 10,000 KPC (p53 mut) cells infected with nontargeting shRNA ( n = 2) as well as shGFER (shGFER#4, n = 2; shGFER#5, n = 3). Tumors were harvested when all tumors were of comparable size. Immune system–related genes are highlighted in red boxes. G, Protein levels of chemokines ( CXCL9, CXCL10 , and CXCL11 ) related to <t>CD8</t> + T-cell infiltration in orthotopic shCTRL and shGFER KPC (p53 mut) tumors. Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 4 mice. H and I, Immunophenotyping of orthotopic shCTRL and shGFER KPC tumors. A total of 10,000 KPC cells were injected into the pancreas, and tumors were harvested for multicolor flow cytometry analysis. The percentage of CD8 + T cells, CD4 + T cells, NK cells (NK1.1+ cells), B cells (B220+ cells), macrophages (F4/80+ cells), and dendritic cells (DC; CD11c + cells) were identified in CD45 + cells ( H ). The percentage of PD-1–positive and granzyme B–positive cells were identified in CD8 + and CD8 + PD-1 + cells, respectively ( I ). Fibroblasts were identified as CD45 − EpCAM − αSMA + cells ( J ). Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 5 mice. K, Kaplan–Meier survival analysis of C57BL/6 mice orthotopically implanted with 10,000 KPC (p53 mut) cells infected with shCTRL or shGFER. Mice received either anti-CD8 antibody (10 mg/kg) or rat IgG2a starting 1 day prior to surgery and then intraperitoneally every 7 days for four cycles. Animals were euthanized when tumor volume reached ∼2000 mm 3 . Survival curves were analyzed by one-way ANOVA ( n = 10 per group). L, Growth curves of 10,000 KPC (p53 mut) cells subcutaneously implanted into C57BL/6 mice. Prior to implantation, KPC cells were infected with shCTRL or shGFER. Tumor-bearing mice were treated with IgG control or anti–PD-1 antibodies. Tumor volume was measured every 4 days for 36 days. Statistical analysis was performed using one-way ANOVA. Data represent the mean ± SD; n = 4–7 per group. M, Pancreatic cancer patient with anti–PD-1/anti-CD40 treatment prior to chemotherapy were selected from the PRINCE trial and divided in to GFER-high and -low groups. The overall survival analysis was done with log-rank test ( N = 17).
Cd8 Knockout Ko Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pmc13055638-134-23-29?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
cd8 knockout ko mice - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Jackson Laboratory cd8−/− knockout (ko) mice
A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for <t>CD8a+</t> T-cells, Tregs, and DCs (n = 4 per group).
Cd8−/− Knockout (Ko) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pmc07442596-275-7-11?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
cd8−/− knockout (ko) mice - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Jackson Laboratory cd8 knockout (ko) mice
A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for <t>CD8a+</t> T-cells, Tregs, and DCs (n = 4 per group).
Cd8 Knockout (Ko) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pm30639307-46-16-24?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
cd8 knockout (ko) mice - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Jackson Laboratory male cd8 knockout (ko) mice (b6.129s2-cd8atm1mak/j)
A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for <t>CD8a+</t> T-cells, Tregs, and DCs (n = 4 per group).
Male Cd8 Knockout (Ko) Mice (B6.129s2 Cd8atm1mak/J), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pm26773152-45-0-24?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
male cd8 knockout (ko) mice (b6.129s2-cd8atm1mak/j) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Amgen cd8 knockout (ko) mice on a c57bl/6 background
A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for <t>CD8a+</t> T-cells, Tregs, and DCs (n = 4 per group).
Cd8 Knockout (Ko) Mice On A C57bl/6 Background, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pm19026704-28-11-19?v=Amgen
Average 90 stars, based on 1 article reviews
cd8 knockout (ko) mice on a c57bl/6 background - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Jackson Laboratory cd8 knockout (ko) mice b6.129s2-cd8atm1mak/j
A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for <t>CD8a+</t> T-cells, Tregs, and DCs (n = 4 per group).
Cd8 Knockout (Ko) Mice B6.129s2 Cd8atm1mak/J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pm17139493-31-1-24?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
cd8 knockout (ko) mice b6.129s2-cd8atm1mak/j - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Jackson Laboratory h-2k b , cd4, cd8, cd54 and cd80 gene knockout (ko) mice
A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for <t>CD8a+</t> T-cells, Tregs, and DCs (n = 4 per group).
H 2k B , Cd4, Cd8, Cd54 And Cd80 Gene Knockout (Ko) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pmc02265880-54-31-46?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
h-2k b , cd4, cd8, cd54 and cd80 gene knockout (ko) mice - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Jackson Laboratory b6.129s2cd8atm1mak cd8-knockout (ko, h2b) mice
A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for <t>CD8a+</t> T-cells, Tregs, and DCs (n = 4 per group).
B6.129s2cd8atm1mak Cd8 Knockout (Ko, H2b) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8+knockout+ko+mice/pm15504162-33-0-18?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
b6.129s2cd8atm1mak cd8-knockout (ko, h2b) mice - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Immunogenicity increases upon GFER depletion in PDAC cells. A–E, Gene set enrichment analysis of RNA-seq data reveals the upregulation of the IFNα response ( A ), IFNγ response ( B ), TNFα signaling via NFκB ( C ), inflammatory response ( D ), and IL2–STAT5 signaling ( E ) pathways in GFER-depleted PATC 124 cells infected with sgGFER. A total of 100,000 PATC cells were cultured in six-well plates for 7 days and then measured. F, RNA-seq analysis demonstrates significant changes in gene expression in orthotopic tumor samples derived from 10,000 KPC (p53 mut) cells infected with nontargeting shRNA ( n = 2) as well as shGFER (shGFER#4, n = 2; shGFER#5, n = 3). Tumors were harvested when all tumors were of comparable size. Immune system–related genes are highlighted in red boxes. G, Protein levels of chemokines ( CXCL9, CXCL10 , and CXCL11 ) related to CD8 + T-cell infiltration in orthotopic shCTRL and shGFER KPC (p53 mut) tumors. Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 4 mice. H and I, Immunophenotyping of orthotopic shCTRL and shGFER KPC tumors. A total of 10,000 KPC cells were injected into the pancreas, and tumors were harvested for multicolor flow cytometry analysis. The percentage of CD8 + T cells, CD4 + T cells, NK cells (NK1.1+ cells), B cells (B220+ cells), macrophages (F4/80+ cells), and dendritic cells (DC; CD11c + cells) were identified in CD45 + cells ( H ). The percentage of PD-1–positive and granzyme B–positive cells were identified in CD8 + and CD8 + PD-1 + cells, respectively ( I ). Fibroblasts were identified as CD45 − EpCAM − αSMA + cells ( J ). Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 5 mice. K, Kaplan–Meier survival analysis of C57BL/6 mice orthotopically implanted with 10,000 KPC (p53 mut) cells infected with shCTRL or shGFER. Mice received either anti-CD8 antibody (10 mg/kg) or rat IgG2a starting 1 day prior to surgery and then intraperitoneally every 7 days for four cycles. Animals were euthanized when tumor volume reached ∼2000 mm 3 . Survival curves were analyzed by one-way ANOVA ( n = 10 per group). L, Growth curves of 10,000 KPC (p53 mut) cells subcutaneously implanted into C57BL/6 mice. Prior to implantation, KPC cells were infected with shCTRL or shGFER. Tumor-bearing mice were treated with IgG control or anti–PD-1 antibodies. Tumor volume was measured every 4 days for 36 days. Statistical analysis was performed using one-way ANOVA. Data represent the mean ± SD; n = 4–7 per group. M, Pancreatic cancer patient with anti–PD-1/anti-CD40 treatment prior to chemotherapy were selected from the PRINCE trial and divided in to GFER-high and -low groups. The overall survival analysis was done with log-rank test ( N = 17).

Journal: Cancer Research

Article Title: GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma

doi: 10.1158/0008-5472.CAN-24-4211

Figure Lengend Snippet: Immunogenicity increases upon GFER depletion in PDAC cells. A–E, Gene set enrichment analysis of RNA-seq data reveals the upregulation of the IFNα response ( A ), IFNγ response ( B ), TNFα signaling via NFκB ( C ), inflammatory response ( D ), and IL2–STAT5 signaling ( E ) pathways in GFER-depleted PATC 124 cells infected with sgGFER. A total of 100,000 PATC cells were cultured in six-well plates for 7 days and then measured. F, RNA-seq analysis demonstrates significant changes in gene expression in orthotopic tumor samples derived from 10,000 KPC (p53 mut) cells infected with nontargeting shRNA ( n = 2) as well as shGFER (shGFER#4, n = 2; shGFER#5, n = 3). Tumors were harvested when all tumors were of comparable size. Immune system–related genes are highlighted in red boxes. G, Protein levels of chemokines ( CXCL9, CXCL10 , and CXCL11 ) related to CD8 + T-cell infiltration in orthotopic shCTRL and shGFER KPC (p53 mut) tumors. Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 4 mice. H and I, Immunophenotyping of orthotopic shCTRL and shGFER KPC tumors. A total of 10,000 KPC cells were injected into the pancreas, and tumors were harvested for multicolor flow cytometry analysis. The percentage of CD8 + T cells, CD4 + T cells, NK cells (NK1.1+ cells), B cells (B220+ cells), macrophages (F4/80+ cells), and dendritic cells (DC; CD11c + cells) were identified in CD45 + cells ( H ). The percentage of PD-1–positive and granzyme B–positive cells were identified in CD8 + and CD8 + PD-1 + cells, respectively ( I ). Fibroblasts were identified as CD45 − EpCAM − αSMA + cells ( J ). Statistical analysis was performed using a two-tailed Student unpaired t test. Data represent the mean ± SD; n = 5 mice. K, Kaplan–Meier survival analysis of C57BL/6 mice orthotopically implanted with 10,000 KPC (p53 mut) cells infected with shCTRL or shGFER. Mice received either anti-CD8 antibody (10 mg/kg) or rat IgG2a starting 1 day prior to surgery and then intraperitoneally every 7 days for four cycles. Animals were euthanized when tumor volume reached ∼2000 mm 3 . Survival curves were analyzed by one-way ANOVA ( n = 10 per group). L, Growth curves of 10,000 KPC (p53 mut) cells subcutaneously implanted into C57BL/6 mice. Prior to implantation, KPC cells were infected with shCTRL or shGFER. Tumor-bearing mice were treated with IgG control or anti–PD-1 antibodies. Tumor volume was measured every 4 days for 36 days. Statistical analysis was performed using one-way ANOVA. Data represent the mean ± SD; n = 4–7 per group. M, Pancreatic cancer patient with anti–PD-1/anti-CD40 treatment prior to chemotherapy were selected from the PRINCE trial and divided in to GFER-high and -low groups. The overall survival analysis was done with log-rank test ( N = 17).

Article Snippet: We used 8-week-old male or female nude mice (Strain #002019, The Jackson Laboratory) and immunocompetent C57BL/6J mice (Strain #000664, The Jackson Laboratory) and CD8 knockout (KO) mice (Strain #002665, The Jackson Laboratory) to establish subcutaneous and orthotopic models, with n = 3–10 mice per treatment group.

Techniques: Immunopeptidomics, RNA Sequencing, Infection, Cell Culture, Gene Expression, Derivative Assay, shRNA, Two Tailed Test, Injection, Flow Cytometry, Control

A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for CD8a+ T-cells, Tregs, and DCs (n = 4 per group).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Article Title: Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas

doi: 10.1158/1078-0432.CCR-20-0341

Figure Lengend Snippet: A-E) C57BL/6 mice inoculated s.c. with 1.2 × 106 GL261 tumor cells were vaccinated on day 20 and administered with anti-PD-L1 on days 21 and 24. On day 26, tumor tissues were stained with antibodies and analyzed by flow cytometry for CD8a+ T-cells, Tregs, and DCs (n = 4 per group).

Article Snippet: Immunocompetent female C57BL/6 or immunocompromised CD4−/− and CD8−/− knockout (KO) mice (Jackson Laboratory) were stereotactically injected with 20,000 GL261 cells into the right striatum using a 22-gauge Hamilton syringe (1 μL over 1 minute) with the following coordinates: +1.00 mm anterior, 2.5 mm lateral, and 3.00 mm deep to establish brain tumors ( 36 – 39 ).

Techniques: Staining, Flow Cytometry

A) Treatment regimen and study timeline. B) IFN-γ ELISPOT assays were performed using PBMCs on day 7 after prime (left) and boost (right) vaccinations (n = 3 per group). C) Kaplan-Meier overall survival curves for all treatment groups (n = 10 per group). D) Kaplan-Meier survival analysis of long-term survivors from (C) re-challenged with GL261 cells in the contralateral hemisphere. E) CD4−/− KO mice or F) CD8−/− KO mice carrying orthotopic GL261 tumors were treated with nanodisc vaccine + anti-PD-L1 therapy as in A) and monitored for survival (n = 5 per group).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Article Title: Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas

doi: 10.1158/1078-0432.CCR-20-0341

Figure Lengend Snippet: A) Treatment regimen and study timeline. B) IFN-γ ELISPOT assays were performed using PBMCs on day 7 after prime (left) and boost (right) vaccinations (n = 3 per group). C) Kaplan-Meier overall survival curves for all treatment groups (n = 10 per group). D) Kaplan-Meier survival analysis of long-term survivors from (C) re-challenged with GL261 cells in the contralateral hemisphere. E) CD4−/− KO mice or F) CD8−/− KO mice carrying orthotopic GL261 tumors were treated with nanodisc vaccine + anti-PD-L1 therapy as in A) and monitored for survival (n = 5 per group).

Article Snippet: Immunocompetent female C57BL/6 or immunocompromised CD4−/− and CD8−/− knockout (KO) mice (Jackson Laboratory) were stereotactically injected with 20,000 GL261 cells into the right striatum using a 22-gauge Hamilton syringe (1 μL over 1 minute) with the following coordinates: +1.00 mm anterior, 2.5 mm lateral, and 3.00 mm deep to establish brain tumors ( 36 – 39 ).

Techniques: Enzyme-linked Immunospot

A-I) C57BL/6 mice were inoculated with GL261 cells and treated as in
Figure 5, and tumors were isolated on day 23 and analyzed by flow cytometry (n =
5 per group). Shown are A) CD8α+ T cells among all T cells, B) PD-1
receptor expression on CD8α+ T cells, C) CD25+Foxp3+ regulatory T cells
among CD4+ T cells, D) ratio of CD8α+ T cells to regulatory T cells, and
E) the ratio of M1 (CD206- F4/80+) to M2 (CD206+ F4/80+) macrophages.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Article Title: Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas

doi: 10.1158/1078-0432.CCR-20-0341

Figure Lengend Snippet: A-I) C57BL/6 mice were inoculated with GL261 cells and treated as in Figure 5, and tumors were isolated on day 23 and analyzed by flow cytometry (n = 5 per group). Shown are A) CD8α+ T cells among all T cells, B) PD-1 receptor expression on CD8α+ T cells, C) CD25+Foxp3+ regulatory T cells among CD4+ T cells, D) ratio of CD8α+ T cells to regulatory T cells, and E) the ratio of M1 (CD206- F4/80+) to M2 (CD206+ F4/80+) macrophages.

Article Snippet: Immunocompetent female C57BL/6 or immunocompromised CD4−/− and CD8−/− knockout (KO) mice (Jackson Laboratory) were stereotactically injected with 20,000 GL261 cells into the right striatum using a 22-gauge Hamilton syringe (1 μL over 1 minute) with the following coordinates: +1.00 mm anterior, 2.5 mm lateral, and 3.00 mm deep to establish brain tumors ( 36 – 39 ).

Techniques: Isolation, Flow Cytometry, Expressing